CNS Pharmaceuticals, Inc. (35)
Browse by Contract Category
Contracts
-
Form of Warrant Amendment Agreement
(Filed With SEC on December 1, 2022)
-
Form of Placement Agency Agreement
(Filed With SEC on December 1, 2022)
-
Non-Employee Director Compensation Policy effective July 15, 2021
(Filed With SEC on August 12, 2022)
-
Engagement Letter between CNS Pharmaceuticals Inc. and H.C. Wainwright & Co., LLC, dated as of January 5, 2022
(Filed With SEC on January 6, 2022)
-
Patent and Technology License Agreement with The Board of Regents of The University of Texas System, an agency of the State of Texas, on behalf of The University of Texas M. D....
(Filed With SEC on March 12, 2020)
-
Form of Securities Purchase Agreement
(Filed With SEC on December 1, 2022)
-
Form of Placement Agent Warrant
(Filed With SEC on December 1, 2022)
-
Form of Pre-Funded Warrant
(Filed With SEC on December 1, 2022)
-
Form of Warrant
(Filed With SEC on December 1, 2022)
-
Form of Common Warrant
(Filed With SEC on November 15, 2022)
-
Form of Pre-Funded Warrant
(Filed With SEC on November 15, 2022)
-
Form of Securities Purchase Agreement
(Filed With SEC on November 15, 2022)
-
Form of Placement Agent Warrant
(Filed With SEC on November 15, 2022)
-
Form of Placement Agency Agreement
(Filed With SEC on November 15, 2022)
-
Form of Warrant
(Filed With SEC on January 6, 2022)
-
Form of Registration Rights Agreement
(Filed With SEC on January 6, 2022)
-
Form of Securities Purchase Agreement
(Filed With SEC on January 6, 2022)
-
Form of Pre-Funded Warrant
(Filed With SEC on January 6, 2022)
-
Non-Employee Director Compensation Policy effective July 15, 2021
(Filed With SEC on November 12, 2021)
-
Capital on Demand Sales Agreement (the Agreement) with JonesTrading Institutional Services LLC and Brookline Capital Markets, a division of Arcadia Securities, LLC
(Filed With SEC on February 12, 2021)
-
Form of Warrant
(Filed With SEC on December 28, 2020)
-
Underwriting Agreement, dated December 22, 2020, with A.G.P./Alliance Global Partners, as representative of the several underwriters
(Filed With SEC on December 28, 2020)
-
Form of Purchase Warrant
(Filed With SEC on December 22, 2020)
-
Form of Underwriting Agreement
(Filed With SEC on December 22, 2020)
-
Form of Pre-Funded Warrant
(Filed With SEC on December 21, 2020)
-
Form of Underwriting Agreement
(Filed With SEC on December 21, 2020)
-
Registration Rights Agreement, dated as of September 15, 2020, by and between the Company and Lincoln Park Capital Fund, LLC
(Filed With SEC on September 21, 2020)
-
Purchase Agreement, dated as of September 15, 2020, by and between the Company and Lincoln Park Capital Fund, LLC
(Filed With SEC on September 21, 2020)
-
Development Agreement between CNS Pharmaceuticals, Inc. and WPD Pharmaceuticals
(Filed With SEC on March 26, 2020)
-
Non-Employee Director Compensation Plan
(Filed With SEC on March 12, 2020)
-
Employment Agreement between CNS Pharmaceuticals, Inc. and Christopher Downs dated September 14, 2019
(Filed With SEC on October 7, 2019)
-
Employment Letter between CNS Pharmaceuticals, Inc. and Donald Picker
(Filed With SEC on July 16, 2019)
-
Form of Underwriter Warrant
(Filed With SEC on July 16, 2019)
-
Employment Letter between CNS Pharmaceuticals, Inc. and Sandra Silberman
(Filed With SEC on July 16, 2019)
-
Form of Underwriting Agreement
(Filed With SEC on July 16, 2019)
